Paper39366383
De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.
Kieliszek AM and 23 others. Cell Rep Med, 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases. Papers, record 39366383. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39366383
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| IMP Dehydrogenase | Major topic |
| Guanosine Triphosphate | Major topic |
| Humans | |
| Animals | |
| Cell Line, Tumor | |
| Mice | |
| Cell Proliferation | |
| Female |
Source PubMed
References70
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17051156 | Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. | Nature | 2006 | https://conductscience.org/library/papers/17051156 | PubMed |
| 2 | 19567251 | ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19567251 | PubMed |
| 3 | 32732914 | Purine metabolism regulates DNA repair and therapy resistance in glioblastoma. | Nat Commun | 2020 | https://conductscience.org/library/papers/32732914 | PubMed |
| 4 | 2389428 | Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis. | Transplant Proc | 1990 | https://conductscience.org/library/papers/2389428 | PubMed |
| 5 | 3537791 | Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. | N Engl J Med | 1986 | https://conductscience.org/library/papers/3537791 | PubMed |
| 6 | 20482838 | Towards a comprehensive structural variation map of an individual human genome. | Genome Biol | 2010 | https://conductscience.org/library/papers/20482838 | PubMed |
| 7 | 30324509 | Introduction to Brain Tumor Stem Cells. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30324509 | PubMed |
| 8 | 36216799 | The spatial transcriptomic landscape of non-small cell lung cancer brain metastasis. | Nat Commun | 2022 | https://conductscience.org/library/papers/36216799 | PubMed |
| 9 | 26627737 | High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities. | Cell | 2015 | https://conductscience.org/library/papers/26627737 | PubMed |
| 10 | 35119267 | Discovery of HDAC6-Selective Inhibitor NN-390 with in Vitro Efficacy in Group 3 Medulloblastoma. | J Med Chem | 2022 | https://conductscience.org/library/papers/35119267 | PubMed |
| 11 | 30565508 | Brain Glucose Metabolism: Integration of Energetics with Function. | Physiol Rev | 2019 | https://conductscience.org/library/papers/30565508 | PubMed |
| 12 | 15620875 | Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier. | Int J Pharm | 2005 | https://conductscience.org/library/papers/15620875 | PubMed |
| 13 | 33858368 | Differentiation of brain metastases from small and non-small lung cancers using apparent diffusion coefficient (ADC) maps. | BMC Med Imaging | 2021 | https://conductscience.org/library/papers/33858368 | PubMed |
| 14 | 26410082 | Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets. | Cancer Discov | 2015 | https://conductscience.org/library/papers/26410082 | PubMed |
| 15 | 29945963 | Cotargeting Ephrin Receptor Tyrosine Kinases A2 and A3 in Cancer Stem Cells Reduces Growth of Recurrent Glioblastoma. | Cancer Res | 2018 | https://conductscience.org/library/papers/29945963 | PubMed |
| 16 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 17 | 30324515 | In Vitro Self-Renewal Assays for Brain Tumor Stem Cells. | Methods Mol Biol | 2019 | https://conductscience.org/library/papers/30324515 | PubMed |
| 18 | 34850156 | Low and steady wins the race: For melanoma brain metastases, is prevention better than a cure? | Neuro Oncol | 2022 | https://conductscience.org/library/papers/34850156 | PubMed |
| 19 | 22869594 | The evolving concept of cancer and metastasis stem cells. | J Cell Biol | 2012 | https://conductscience.org/library/papers/22869594 | PubMed |
| 20 | 21666715 | Gamma-secretase inhibitors target tumor-initiating cells in a mouse model of ERBB2 breast cancer. | Oncogene | 2012 | https://conductscience.org/library/papers/21666715 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42221081 | Metabolic reprogramming in sepsis-associated encephalopathy: emerging mechanisms, candidate biomarkers, and future therapeutic directions. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42221081 | PubMed |
| 41881963 | The oncogenic control of nucleotide synthesis. | Oncogenesis | 2026 | https://conductscience.org/library/papers/41881963 | PubMed |
| 41608571 | Coupling proteostasis and de novo purine biosynthesis of PSMD14 fuels glioblastoma progression and chemoresistance. | Theranostics | 2026 | https://conductscience.org/library/papers/41608571 | PubMed |
| 41579862 | Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41579862 | PubMed |
| 41467070 | Identification of non-oncology drugs with activity against inflammatory and triple-negative breast cancer cell lines. | Oncol Lett | 2026 | https://conductscience.org/library/papers/41467070 | PubMed |
| 41292630 | Adaptive nuclear GTP synthesis promotes glioblastoma treatment resistance and is a targetable vulnerability in patients. | medRxiv | 2025 | https://conductscience.org/library/papers/41292630 | PubMed |
| 41154443 | A Novel Allosteric Inhibitor Targeting IMPDH at Y233 Overcomes Resistance to Tyrosine Kinase Inhibitors in Lymphoma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41154443 | PubMed |
| 41055774 | Transcriptional regulation of nucleotide metabolism in medulloblastoma subtypes and prognostic implications analyzed by RNA-Seq. | J Cancer Res Clin Oncol | 2025 | https://conductscience.org/library/papers/41055774 | PubMed |
| 40707738 | Metabolic adaptations of brain metastasis. | Nat Rev Cancer | 2025 | https://conductscience.org/library/papers/40707738 | PubMed |
| 40601773 | A genome-wide in vivo CRISPR activation screen identifies BACE1 as a therapeutic vulnerability of lung cancer brain metastasis. | Sci Transl Med | 2025 | https://conductscience.org/library/papers/40601773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39366383
GET https://conductscience.org/api/papers/v1/39366383/authors?page=2